Advocacy intelligence hub — real-time data for patient organizations
Lialda: FDA approved
Lialda (mesalamine) is indicated for the treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.
Cetylev: FDA approved
Indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Cetylev
Arbor Pharmaceuticals, Inc.
Lialda
(mesalamine; 5-aminosalicylic acid)Orphan drugTakeda Development Center Americas, Inc.
Aminosalicylate [EPC]
12.1 Mechanism of Action The mechanism of action of mesalamine is not fully understood, but it appears to have a topical anti-inflammatory effect on t...
Cetylev
(acetylcysteine effervescent tablets for oral solution)Orphan drugArbor Pharmaceuticals, Inc.
View all NON RARE IN EUROPE: Peyronie syndrome specialists →